vs
Esquire Financial Holdings, Inc.（ESQ）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
Esquire Financial Holdings, Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.1倍（$40.5M vs $35.5M），Esquire Financial Holdings, Inc.净利率更高（30.2% vs -304.2%，领先334.4%），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 15.0%）
Esquire Financial Holdings是一家总部位于美国的银行控股公司，提供全面的商业及零售银行服务，核心业务包含存款账户、企业贷款、按揭服务及财富管理解决方案，主要服务中小型企业、法律行业从业者及当地零售客户。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
ESQ vs RXRX — 直观对比
营收规模更大
ESQ
是对方的1.1倍
$35.5M
净利率更高
ESQ
高出334.4%
-304.2%
两年增速更快
RXRX
近两年复合增速
15.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $40.5M | $35.5M |
| 净利润 | $12.2M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | — | -304.8% |
| 净利率 | 30.2% | -304.2% |
| 营收同比 | — | 681.7% |
| 净利润同比 | 7.0% | 39.6% |
| 每股收益（稀释后） | $1.40 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESQRXRX
| Q1 26 | $40.5M | — | ||
| Q4 25 | $39.4M | $35.5M | ||
| Q3 25 | $37.6M | $5.2M | ||
| Q2 25 | $35.8M | $19.2M | ||
| Q1 25 | $33.8M | $14.7M | ||
| Q4 24 | $33.1M | $4.5M | ||
| Q3 24 | $31.9M | $26.1M | ||
| Q2 24 | $30.6M | $14.4M |
净利润ESQRXRX
| Q1 26 | $12.2M | — | ||
| Q4 25 | $13.5M | $-108.1M | ||
| Q3 25 | $14.1M | $-162.3M | ||
| Q2 25 | $11.9M | $-171.9M | ||
| Q1 25 | $11.4M | $-202.5M | ||
| Q4 24 | $11.8M | $-178.9M | ||
| Q3 24 | $11.4M | $-95.8M | ||
| Q2 24 | $10.5M | $-97.5M |
毛利率ESQRXRX
| Q1 26 | — | — | ||
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% |
营业利润率ESQRXRX
| Q1 26 | — | — | ||
| Q4 25 | 44.3% | -304.8% | ||
| Q3 25 | 46.5% | -3327.6% | ||
| Q2 25 | 42.5% | -916.8% | ||
| Q1 25 | 45.9% | -1297.9% | ||
| Q4 24 | 47.4% | -4042.4% | ||
| Q3 24 | 48.8% | -377.1% | ||
| Q2 24 | 46.9% | -697.4% |
净利率ESQRXRX
| Q1 26 | 30.2% | — | ||
| Q4 25 | 34.2% | -304.2% | ||
| Q3 25 | 37.4% | -3135.3% | ||
| Q2 25 | 33.2% | -894.2% | ||
| Q1 25 | 33.8% | -1373.3% | ||
| Q4 24 | 35.6% | -3935.5% | ||
| Q3 24 | 35.6% | -367.5% | ||
| Q2 24 | 34.3% | -676.6% |
每股收益（稀释后）ESQRXRX
| Q1 26 | $1.40 | — | ||
| Q4 25 | $1.54 | $-0.17 | ||
| Q3 25 | $1.62 | $-0.36 | ||
| Q2 25 | $1.38 | $-0.41 | ||
| Q1 25 | $1.33 | $-0.50 | ||
| Q4 24 | $1.35 | $-0.56 | ||
| Q3 24 | $1.34 | $-0.34 | ||
| Q2 24 | $1.25 | $-0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $222.2M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $301.3M | $1.1B |
| 总资产 | $2.4B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资ESQRXRX
| Q1 26 | $222.2M | — | ||
| Q4 25 | $235.9M | $743.3M | ||
| Q3 25 | $240.8M | $659.8M | ||
| Q2 25 | $163.0M | $525.1M | ||
| Q1 25 | $173.0M | $500.5M | ||
| Q4 24 | $126.3M | $594.4M | ||
| Q3 24 | $147.7M | $427.6M | ||
| Q2 24 | $152.7M | $474.3M |
总债务ESQRXRX
| Q1 26 | — | — | ||
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M |
股东权益ESQRXRX
| Q1 26 | $301.3M | — | ||
| Q4 25 | $289.6M | $1.1B | ||
| Q3 25 | $279.2M | $1.0B | ||
| Q2 25 | $263.6M | $919.1M | ||
| Q1 25 | $250.7M | $933.9M | ||
| Q4 24 | $237.1M | $1.0B | ||
| Q3 24 | $232.6M | $524.6M | ||
| Q2 24 | $217.4M | $584.4M |
总资产ESQRXRX
| Q1 26 | $2.4B | — | ||
| Q4 25 | $2.4B | $1.5B | ||
| Q3 25 | $2.2B | $1.4B | ||
| Q2 25 | $2.1B | $1.3B | ||
| Q1 25 | $2.0B | $1.3B | ||
| Q4 24 | $1.9B | $1.4B | ||
| Q3 24 | $1.8B | $726.5M | ||
| Q2 24 | $1.7B | $775.9M |
负债/权益比ESQRXRX
| Q1 26 | — | — | ||
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
经营现金流ESQRXRX
| Q1 26 | — | — | ||
| Q4 25 | $59.8M | $-46.1M | ||
| Q3 25 | $16.8M | $-117.4M | ||
| Q2 25 | $10.5M | $-76.4M | ||
| Q1 25 | $15.8M | $-132.0M | ||
| Q4 24 | $42.2M | $-115.4M | ||
| Q3 24 | $10.5M | $-59.2M | ||
| Q2 24 | $7.2M | $-82.2M |
自由现金流ESQRXRX
| Q1 26 | — | — | ||
| Q4 25 | $56.7M | $-47.3M | ||
| Q3 25 | $16.2M | $-117.6M | ||
| Q2 25 | $9.3M | $-79.6M | ||
| Q1 25 | $14.7M | $-133.8M | ||
| Q4 24 | $41.5M | $-116.7M | ||
| Q3 24 | $10.5M | $-63.8M | ||
| Q2 24 | $6.9M | $-83.4M |
自由现金流率ESQRXRX
| Q1 26 | — | — | ||
| Q4 25 | 143.9% | -133.1% | ||
| Q3 25 | 43.2% | -2272.5% | ||
| Q2 25 | 26.0% | -413.9% | ||
| Q1 25 | 43.4% | -907.4% | ||
| Q4 24 | 125.5% | -2567.7% | ||
| Q3 24 | 32.8% | -244.6% | ||
| Q2 24 | 22.5% | -578.5% |
资本支出强度ESQRXRX
| Q1 26 | — | — | ||
| Q4 25 | 8.0% | 3.5% | ||
| Q3 25 | 1.3% | 4.7% | ||
| Q2 25 | 3.2% | 16.4% | ||
| Q1 25 | 3.4% | 12.4% | ||
| Q4 24 | 2.2% | 28.6% | ||
| Q3 24 | 0.2% | 17.5% | ||
| Q2 24 | 1.1% | 8.2% |
现金转化率ESQRXRX
| Q1 26 | — | — | ||
| Q4 25 | 4.44× | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | 0.88× | — | ||
| Q1 25 | 1.39× | — | ||
| Q4 24 | 3.59× | — | ||
| Q3 24 | 0.93× | — | ||
| Q2 24 | 0.69× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESQ
| Net Interest Income | $34.0M | 84% |
| Noninterest Income | $6.5M | 16% |
RXRX
暂无分部数据
